Home » Stocks » Electromed

Electromed, Inc. (ELMD)

Stock Price: $9.12 USD -0.13 (-1.41%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 78.44M
Revenue (ttm) 32.47M
Net Income (ttm) 4.16M
Shares Out 8.60M
EPS (ttm) 0.47
PE Ratio 19.40
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 23, 2020
Last Price $9.12
Previous Close $9.25
Change ($) -0.13
Change (%) -1.41%
Day's Open 9.37
Day's Range 9.12 - 9.40
Day's Volume 37,026
52-Week Range 6.61 - 19.73

More Stats

Market Cap 78.44M
Enterprise Value 67.96M
Earnings Date (est) Nov 17, 2020
Ex-Dividend Date n/a
Shares Outstanding 8.60M
Float 6.73M
EPS (basic) 0.50
EPS (diluted) 0.47
FCF / Share 0.40
Dividend n/a
Dividend Yield n/a
Earnings Yield 5.15%
FCF Yield 4.27%
Payout Ratio n/a
Shares Short 331,129
Short Ratio 2.83
Short % of Float 4.92%
Beta 0.30
PE Ratio 19.40
Forward PE n/a
P/FCF Ratio 23.40
PS Ratio 2.42
PB Ratio 2.63
Revenue 32.47M
Operating Income 5.12M
Net Income 4.16M
Free Cash Flow 3.35M
Net Cash 10.48M
Net Cash / Share 1.22
Gross Margin 77.61%
Operating Margin 15.76%
Profit Margin 12.80%
FCF Margin 10.32%
ROA 8.39%
ROE 14.87%
ROIC 27.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$19.00*
Low
19.0
Current: $9.12
High
19.0
Target: 19.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2020201920182017201620152014201320122011
Revenue32.4731.3028.3125.8622.9919.4115.4915.1019.5219.00
Revenue Growth3.74%10.57%9.46%12.48%18.46%25.31%2.54%-22.64%2.74%-
Gross Profit25.2023.8521.7720.5717.8813.6010.6310.4514.1513.78
Operating Income5.122.832.713.573.111.31-0.74-1.830.611.87
Net Income4.161.981.832.232.211.09-1.29-1.330.191.06
Shares Outstanding8.408.318.218.178.148.128.118.118.117.82
Earnings Per Share0.470.230.210.260.270.13-0.16-0.160.020.13
EPS Growth104.35%9.52%-19.23%-3.7%107.69%----84.62%-
Operating Cash Flow4.202.592.441.192.172.782.071.88-1.17-1.42
Capital Expenditures-0.84-1.33-0.53-0.62-0.53-0.52-0.90-1.02-0.79-0.45
Free Cash Flow3.351.261.920.571.632.261.170.86-1.96-1.87
Cash & Equivalents10.487.817.465.575.123.601.500.501.704.09
Total Debt--1.101.151.191.251.301.393.413.79
Net Cash / Debt10.487.816.354.433.932.350.21-0.89-1.710.30
Assets33.2429.4027.3923.0620.5817.4115.7917.5620.9220.87
Liabilities3.003.674.803.994.223.483.073.635.846.16
Book Value30.2525.7322.5919.0716.3613.9212.7213.9315.0814.71
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Electromed, Inc.
Country United States
Employees 120
CEO Kathleen S. Skarvan

Stock Information

Ticker Symbol ELMD
Stock Exchange NYSE American
Sector Healthcare
Industry Medical Devices
Unique Identifier NYSEAMERICAN: ELMD
IPO Date August 13, 2010

Description

Electromed develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of all ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.